Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS) Shares Sold by JPMorgan Chase & Co.
JPMorgan Chase & Co. reduced its position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 50.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 24,455 shares of the company’s stock after selling 25,101 shares during the quarter. JPMorgan Chase & Co.’s holdings […]
JPMorgan Chase & Co. reduced its position in Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Free Report) by 50.7% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 24,455 shares of the company’s stock after selling 25,101 shares during the quarter. JPMorgan Chase & Co.’s holdings […]
